| Purity | ≥98% |
| Molecular Weight | 3,731.3 Da |
| Category | Long-Acting Amylin Analog |
GLP-1 CAG
A long-acting amylin analog studied alongside incretin agonists for its complementary signalling pathway.
Starting from $62.99
| Qty | Per vial | Discount |
|---|---|---|
| 1 | $62.99 | — |
| 3 | $56.69 | 10% off |
| 5 | $53.54 | 15% off |
| 10 | $49.13 | 22% off |
For research use only. Not for human consumption.
Frequently bought together
GLP-1 Sema10 mg · $45.00
- GLP-1 CAG
5 mg · $62.99
$107.99 $104.00 save $3.99 (4%)
Added as the Incretin + Amylin Pair, priced as one line.
Needs reconstituting
Supplied as lyophilised powder. Reconstitution Liquid 10 mL · $19.99
Storage Conditions
Store lyophilised powder at -20°C, protected from light. Reconstituted material at 2-8°C, use within 30 days.
Overview
Cagrilintide is an acylated, long-acting analog of human amylin, studied for its activity at amylin and calcitonin receptors. Research interest centres on its pairing with incretin receptor agonists, where the two act through distinct pathways. Supplied lyophilised for in-vitro laboratory research only.
Reviews
No reviews yet — be the first to share your research experience.
Research use only. This product is intended for in vitro and laboratory research purposes only. It is not approved by the FDA for human or veterinary use. It is not a drug, food, or cosmetic, and may not be misbranded, misused, or sold for purposes other than research.
All information provided is for research and educational purposes only and does not constitute medical advice.